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Abstract This review describes the relationships and links
between culture collections, which act as sources of ge-
nomes, transcriptomes, proteome, and metabolomes,
and ﬁelds of research biochemistry that demand their
support and help. In addition, the invaluable but not
always rewarded eﬀorts of these organizations as a
source and conservator of organism diversity is dis-
cussed. Biological waste-water treatment, ethanol as a
non-ﬁnite source of energy, Rhodococcus fascians as the
source of a citrus-juice debittering agent, the sporulation
of ﬁlamentous fungi in liquid medium, and biotransfor-
mation with growing and resting cells are processes
developed by the authors that demonstrate some of the
applications of organisms from culture collections in the
general ﬁeld of biotechnology and related areas, includ-
ing industrial biochemistry and biocatalytic synthesis.
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Introduction
Microorganisms can be isolated from nature or obtained
as pure cultures from permanent culture repositories.
Industrially important microbial cultures are perma-
nently preserved if they are of interest or useful. How-
ever, culture collections are much more than places for
the deposit and supply of cultures. These resource cen-
ters are managed by mycologists, yeast and bacteria
curators, and, nowadays, eukaryotic cell-line experts
who provide advice on the speciﬁc culture of interest and
its properties, identiﬁcation (locality of origin, substrate,
host, date of isolation/construction, name of person who
isolated/constructed the resource, depositor, etc.) and
preservation (methods applied, cultivation conditions,
security and quality codes, characteristics, and restric-
tions). In addition, training and specialist services to
industry on a contract consultant basis are available
from the largest collections, a number of which also act
as depositories for patent strains [22, 23, 32].
A growing awareness of the importance of biodiver-
sity and its hidden genetic potential has resulted in both
growing recognition of the value of culture collections of
microorganisms and an increase in the number of such
collections [22, 32]. Culture collections are long-term
commitments, as explained in the guidelines of the
World Federation for Culture Collections (WFCC) [23].
Culture collections are labour-intensive: accession,
preservation and maintenance as well as the constant
necessity to check the viability and to authenticate the
biological material mean that good laboratory practice
has to be guaranteed.
Culture collections and biochemistry
The connection between culture collections and bio-
chemistry and molecular biology is so obvious and
important that one only needs to recall the deﬁnition of
biochemistry: ‘‘[That] part of chemistry that studies the
chemical composition and chemical reactions taking
place within living things’’ [33]. For a biochemist, the
study of either catalogue-known or research-screened
microorganisms means that sooner or later he/she will
be dealing with culture collection experts, since advice
and/or a ﬁnal deposit will be required. From an aca-
demic point of view, biochemistry students are taught
cell biology (the structure and function of cellular
components), enzymology, metabolism and its regula-
tion, and most biochemistry textbooks cite examples
from catalogued microorganisms (Escherichia coli,
Bacillus subtilis, etc). Hence, culture collections have
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always been the mainstay of the biochemist’s teaching
and research duties.
Culture collections, as sources for genome, tran-
scriptome, proteome and metabolome, provide tools for
biochemists and molecular biologists. In turn, bio-
chemists and molecular biologists contribute knowledge,
methodology, and techniques to an interdisciplinary
approach known as biotechnology. Recent advances in
biotechnology are being explored for their use in the
treatment of metabolic disorders and genetic diseases.
Furthermore, innovations in food production, environ-
mental problem-solving technologies, and many other
areas previously the domain of the chemical industry
have been made by exploiting the metabolic character-
istics of a wide variety of microorganisms. The rela-
tionship and the links between culture collections and
biotechnology are discussed below.
Biotechnology and industrial biochemistry
Biotechnology requires the existence of culture collec-
tions since the microorganisms maintained in them pro-
vide biocatalysts as well as sources of compounds with a
wide variety of research and industrial applications. As a
component of biotechnology, industrial biochemistry has
been deﬁned as ‘‘the science that studies the biochemical
background/foundation of the biosystems used by bio-
industry’’[3]. In general, industrial biochemistry uses
microorganisms either from culture collections or from
screening projects and studies the stoichiometry and
kinetics in closed and open environments (bioreactors),
where bioprocesses are carried out in order to obtain
products for the pharmaceutical, agricultural, and food
industries. A very speciﬁc part of industrial biochemistry
is that related to applied biocatalysis, also referred to as
biocatalytic synthesis. This concerns ‘‘the use of biocat-
alysts such as enzymes, catalytic antibodies, artiﬁcial
enzymes, organules and whole cells for the production of
compounds’’ [3]. Its aims include how to stabilize bio-
catalysts, how to improve both their catalytic charac-
teristics and the environments (open and closed
bioreactors) in which they operate. A precise imple-
mentation and understanding of any biological process
requires that culture collection experts must be con-
sulted. Nowadays, the use of microorganisms for the
production of everyday products has become routine in
bioindustry. As early as 1929, J.B.S. Haldane was asked
by a journalist for his opinion about pure chemists and
their job, and he replied with the following joke: ‘‘Why
trouble yourself to make compounds yourself when a
bug will do it for you’’ [21]. Since then, many new tech-
niques have been developed, such as cell culturing,
reactor engineering, recombinant DNA, PCR, DNA
shuﬄing, site-directed mutagenesis, metabolic engineer-
ing, protein engineering, and artiﬁcial enzyme synthesis.
All these techniques and the resulting new-found
knowledge have their applications in biotechnology, but
always in connection with culture collections that supply
the catalogued organisms. Research, then, begins and
ends with such collections since the result, once modiﬁed
and patented, is deposited in a culture collection. In fact,
bioindustry, within a very short period of time, has pu-
shed the scientiﬁc community to develop and apply new
techniques to studying microorganisms, ﬁlamentous
fungi, yeast, plant cells and mammalian cell lines, so as to
be able to transform not only organic but also inorganic
materials to yield products for the pharmaceutical,
agricultural and food industries. Bioindustry requires
culture collections as genome and proteome sources.
More importantly, however, metabolic proﬁling—the
metabolome era—is nowadays of critical importance for
implementing new biotechnological processes and for
developing new biocatalysts and techniques.
Biochemistry and molecular biology have focused
their attention on four main areas: (1) signal transduc-
tion in cells; (2) protein engineering (structure and
function, structure and activity, and structure and sta-
bility); (3) recombinant DNA technology, as a tool for
studying and improving structure and function; and (4)
metabolic engineering as a way to re-direct metabolic
ﬂuxes. Industrial biochemistry has used the resulting
knowledge to optimize not only biocatalysts but also
many other industrially oriented bioprocesses.
Some examples of bioprocesses that the authors have
developed demonstrate the importance of culture col-
lections in biochemistry and molecular biology research
with applications to industrial biochemistry. These are
described in the following sections.
Some examples of bioprocesses
Parallel to the development of what has been referred to
as classical biotechnology, i.e., the manufacture of food-
enhancers (ﬂavours and aromas) and food-products
(dairy products, meat products, etc.), interest in other
biotechnological processes, such as solvent production
(acetone-butanol fermentation), antibiotics, and partic-
ularly bioremediation (waste-water treatment, aerobic
and anaerobic organic matter degradation) has grown
and many advances have been made.
Biological waste-water treatment
Among waste-water treatment methods, anaerobic
digestion involves transforming organic matter into sub-
strates for cellular growth (10–15%), and a mixture of
CH4, CO2 and H2S (85–90%), by a consortia of bacteria
resembling an electron chain, inwhich organicmatter acts
as electron donor and acceptor. There are three diﬀerent
groups of bacteria (acidogenic, acetogenic and H2-pro-
ducing acetogenic and methanogenic) that consume a gi-
ven substrate and produce substrates for the next group,
the bottle-neck being methanogens due to their slow rate
of growth [11]. Unfortunately, anaerobic digestion pro-
cesses require long start-up times before operation is
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eﬃcient and stable because of the slow growth of acetate-
and CO2- as well as H2-consuming methanogens. Fixed-
ﬁlm reactors to increase the biomass retention of the
reactor were a signiﬁcant advance [11, 12], and new bac-
teria were characterized and catalogued while the process
was being evaluated. New high-rate anaerobic reactors
and a novel method to accelerate the start-up of a down-
ﬂow percolating ﬁxed-ﬁlm anaerobic reactor were devel-
oped [2, 13] by growing both acidogenic and interspecies
H2-producing/H2-consuming bacteria during two sub-
sequent stages of reactor start-up [12, 27]. A model
describing the stratiﬁed growth of the acidogenic and the
methanogenic populations within the bioﬁlm was gener-
ated, while the presence of the F420 cofactor within
methanogens was detected and used as a means of mea-
suring methanogenic growth [7, 13]. From 1980 to 1990 a
great number of new microorganisms and strains were
referenced and catalogued; thesewere deposited in culture
collections where they could be compared with previously
characterized strains [38]. Part of our work was to main-
tain the cells by immobilizing them onto solid supports,
either porous or non-porous material, and to compare
microorganisms catalogued in the Spanish Type Culture
Collection (CECT) with microorganisms observed in the
reactor [7]. Table 1 lists both the type of cell-retention
material and the reactor used in order to support cell
growth and compound production.
Ethanol as a non-ﬁnite source of energy
Due to their ﬁnite nature and continuing ﬂuctuations in
the price of fossil fuels (coal and petrol), interest in new
and durable energy sources has increased. When we
started our study of ethanol metabolism in Zymomonas
mobilis, ethanol was a priority area of research within
the European Community. Strain Z. mobilis ZM4 was
kindly supplied by Prof. Baratti (INSA, Toulouse,
France) and a ﬂocculent strain obtained by our group
was deposited in the CECT (CECT no. 560). Z. mobilis
metabolizes glucose, fructose and sucrose by the Entner-
Doudoroﬀ pathway. This metabolism was studied using
diﬀerent types of reactors and diﬀerent immobilization
supports for cell retention. Long-term culture of our
Z. mobilis strain in an immobilized cell reactor
conﬁrmed its genetic stability [14, 15, 26] (Table 1).
Rhodococcus fascians, a citrus-juice debittering organism
The bitterness of certain citrus juices due to limonin is a
major problem in the citrus industry worldwide and has
signiﬁcant economic impact. The naturally occurring
form and precursor of limonin is limonoate A ring lac-
tone [4]. After the juice is extracted, this limonoid moves
into the liquid phase where it is chemically converted to
limonin in a process accelerated by the acidic pH of the
juices (4.0–5.0) and also by heat. Thus far, Rhodococcus
fascians (CECT 3001) is the only organism that consti-
tutively produces enzymes for the metabolism of limo-
noids [6], consuming limonin as carbon source for
growth. Other bacteria require the presence of a limo-
noid inducer within the growth medium to produce cells
capable of metabolizing limonoids. Despite the advan-
tages of applying this microorganism as a possible cit-
rus-juice-debittering biocatalyst, attempts to apply it in a
commercially viable way were unsuccessful. We com-
pared the behavior of R. fascians cells at the optimum
pH for growth (pH 7.0) and at the usual pH of citrus
juices (pH 4.0), at which cells have lower catalytic
activity [5]. The limonin species used by R. fascians as
possible cellular substrates at pH 4.0 were also tested [4].
In addition, as R. fascians is considered an aerobic
microorganism, the cellular response to the extreme
conditions imposed by the citrus juice (low pH) and the
non-aerated conditions during its industrial processing
were studied [6]. Moreover, with the purpose of ﬁnding a
debittering biocatalytic system, the behavior of free and
immobilized R. fascians cells within batch- and contin-
uous reactors in the presence of synthetic citrus juices
and under the conditions characteristic of processing
citrus juices was monitored. Polyurethane foam was
used as the solid support because of its high structural
stability and biomass retention capability. It is also
harmless to cells [6] and the product obtained is com-
patible with human use (Table 1).
Table 1 Organisms and processes used for cell growth and production of compounds under diﬀerent conditions and immobilized on
diﬀerent solid supports (see text for culture collections)
Organism Immobilization support Product Metabolism Reactor type Reference
Anaerobic
Mixed cultures
Needle punched polyester Methane Anaerobic food
chain from pyruvate
Downﬂow stationary
ﬁxed ﬁlm
[7]
Zymomonas
mobilis
Polyester/cellulose Ethanol Entner-Doudoroﬀ Packed bed [15]
Rhodococcus
fascians
Polyurethane Fruit juice
debittering
Limonoids Continuous
stirred tank
[5]
Escherichia
coli strains
Various L(–)-carnitine Trimethylammonium
compounds
High-density
cell membrane
[9, 35]
Proteus
mirabilis
Various L(–)-carnitine Trimethylammonium
compounds
High-density
cell membrane
[8]
Penicillium
chrysogenum
Cellulose Various Biotransformations Batch system –
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Filamentous fungi sporulation in submerged liquid
medium
Filamentous fungi have two diﬀerent types of repro-
duction: (1) sexual, which allows vegetative growth
mycelium in liquid/solid media; and (2) asexual, which
allows growth after spore germination [25, 40]. Sporu-
lation methods of Penicillium sp. strains in submerged
liquid media [40] represented a breakthrough in antibi-
otic production and biocatalyst spore production for the
biotransformation of compounds such as steroids and
certain aldehydes. Spore-latent status does not mean that
no metabolic activity takes place. Therefore, in the ﬁeld
of biotransformations great eﬀort is devoted to the use of
spores of ﬁlamentous fungi for the production of com-
pounds neither produced by single enzymes nor by other
organisms [25]. The strains used for our studies were
supplied by the CECT (CECT no. 2668) and by Antibi-
o´ticos S.A. (Leo´n, Spain). The vegetative growth of ﬁl-
amentous fungi in liquid/solid media is aﬀected by the
environmental conditions and the composition of the
growth medium. Morphological changes are likely to be
observed as a result of changes in the environment,
leading to a shift from sexual to asexual (sporulation)
reproduction. By selecting liquid medium containing
divalent cations such as Ca2+ and Mg2+ [40], the spor-
ulation of several Penicillium sp. (Fig. 1) in submerged
cultures was obtained (Ca´novas and Iborra, unpublished
data). Spores were used for the biotransformation of
aldehydes to ketones.
Biotransformations using growing and resting cells
This example is related to work currently being carried
out by our group: optimization of the process for L())-
carnitine synthesis from trimethylammonium com-
pounds using wild-type and transformed Escherichia coli
strains in metabolic and genetic engineering. L())-carni-
tine (R[)]3-hydroxy-4-trimethylaminobutyrate) trans-
ports long-chain fatty acids through the inner
mitochondrial membrane [29], and several clinical
applications for this process have been identiﬁed, lead-
ing to increased demand for this ccompound worldwide
[31]. To satisfy this demand, chemical and biological
production processes are being studied. Processes based
on the chemical resolution of racemic carnitine produce
D(+)-carnitine as a waste product, which can be con-
verted into L())-carnitine by certain microorganisms
(Fig. 2) [31]. Therefore, an otherwise worthless waste
product can be used as substrate to produce a high-value
compound [30]. Escherichia coli cells metabolize carni-
tine (through secondary trimethylammonium metabo-
lism) but do not assimilate the carbon or nitrogen
carnitine skeleton. Initial experiments have shown that
resting or growing E. coli O44 K74 cells biotransform
crotonobetaine into L())-carnitine (Fig. 2) [9, 39]. Fur-
thermore, D(+)-carnitine can also be biotransformed
under batch resting-cell conditions into L())-carnitine
[16, 30]. In parallel, genetic studies were conducted to
elucidate carnitine metabolism in E. coli. Two divergent
structural operons, caiTABCDE and ﬁxABCX, are co-
expressed during cell anaerobic growth in the presence
of L())-carnitine or crotonobetaine [18, 19]. Molecular
characterization of the cai operon has shown that high
levels of carnitine racemase (bifunctional gene caiD) and
L())-carnitine dehydratase (bifunctional gene caiD) as
well as a cofactor (caiE) required for both enzyme
activities are observed in a transformed strain of E. coli,
strain K38 [17, 20].
In our work, E. coli K38 pT7-5KE32 was kindly
provided by Prof. Kleber (University of Leipzig, Ger-
many) and E. coliO44 K74 by DSM (DSM no. 8828) [17,
35]. E. coli K38 pT7–5KE32 (TS) contains the complete
caiTABCDE and ﬁx operons, and the plasmids pGP1-2,
Kanr and pT7-5KE32 (a pBR322 derivative), Ampr,
which carries an insert with caiD, caiE and caiF from the
E. coli cai operon; thus, this strain overexpresses carni-
tine racemase and L())-carnitine dehydratase [17]. The
wild-type strain E. coli O44 K74 (WS) contains the
complete cai and ﬁx operons. The two-step pathway,
including L())-carnitine dehydratase (L())-carnitine hy-
drolyase, protein CaiD) and a crotonobetaine reductase
(protein CaiA) (Fig. 2) [17], is induced anaerobically in
the presence of carnitine and/or crotonobetaine. This
pathway is detectable not only in cells previously grown
anaerobically but, to a lesser extent, also in cells grown
under aerobiosis in the presence of the inducers [30, 36,
37]. To produce L())-carnitine, either the crotonobetaine
reductase gene (caiA) must be knocked-out or the
enzyme (protein CaiA) inhibited (Fig. 2).
Resting and growing cells of E. coli were used in batch
reactors for substrate biotransformation. The term
‘‘resting cell’’ applies to cells that, after growth, are
harvested and resuspended in the biotransformation
medium, which contains D(+)-carnitine or crotonobe-
taine in 55 mM phosphate buﬀer, pH 7.5, in order to
carry out biotransformation of either D(+)-carnitine orFig. 1 Penicillium sp. sporulation in submerged liquid media
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crotonobetaine. During continuous processes, diﬀerent
cell immobilization procedures were utilized [34, 35, 36]
(Table 1, Fig. 3). Membranes were also used to retain
large components (e.g., cells), while allowing small mol-
ecules (i.e., the product) to pass through. Therefore,
high-cell-density membrane reactors were run at diﬀerent
dilution rates, and strategies such as growth followed by
resting periods to maintain continuous production of
L())-carnitine were implemented so that stable operation
was achieved [23, 36].
Furthermore, cell transport of trimethylammonium
was studied under diﬀerent conditions to determine the
kinetics of the protein transporter [28] and its inﬂuence
on the biotransformation of both substrates into L())-
carnitine [1, 9]. The main research aim of our group is to
study and optimize the biotransformation of D(+)-carni-
tine and crotonobetaine into L())-carnitine by obtaining a
detailed understanding of carnitine metabolism and by
overexpressing the relevant enzymes in E.coli. For this
purpose, the activities L())-carnitine dehydratase and
crotonobetaine reductase of E. coli are being studied
under diﬀerent growth conditions in batch and high-cell-
density membrane reactors.
Inﬂuence of electron acceptors: oxygen and fumarate
Resting cell experiments showed a positive inﬂuence of
electron acceptors, such as oxygen and fumarate, on
the D(+)-carnitine racemization process carried out by
WS (Fig. 2) [16, 30]. Higher growth rates and biomass
concentrations of TS were achieved with increased
oxygen concentration. Furthermore, during aerobiosis
TS carried out trimethylammonium metabolism in
which crotonobetaine reductase was not detected
(Fig. 2). Thus, 15–30% oxygen saturation was ﬁxed as
the optimum concentration since L())-carnitine was
obtained without concomitant c-butyrobetaine pro-
duction (Fig. 2). With respect to WS, batch growth
studies during aerobiosis showed that there was little
metabolism of trimethylammonium, unlike during
anaerobiosis, since low levels of L())-carnitine dehy-
dratase and D(+)-carnitine racemase were detected after
growth in the presence of crotonobetaine or D(+)-car-
nitine. Based on these results, the biotransformation
process was improved by the addition of fumarate [16,
35]. However, the role of fumarate in trimethylammo-
nium metabolism by E. coli growing under anaerobiosis
is not totally understood; the eﬀect might be at the
energy-producing or the anaplerotic pathway levels.
Moreover, for both strains, crotonobetaine was shown
to be the best substrate for L())-carnitine production
due to the expression of enzyme activity or to the fact
that membrane transporters for the substrate and
product have been reported to be the same [10],
implying that there are diﬀerent transport aﬃnities.
Overexpression of CaiD
The biotransformation of D(+)-carnitine by TS under
optimal reactor conditions (15–30% oxygen saturation,
41 C, and a minimal medium), resulted in the produc-
tion of 0.15 g L())-carnitine/l/h and a conversion of 32%.
Fig. 2 Metabolism of trimethylammonium compounds in diﬀerent
microorganisms. After [31]
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Moreover, no plasmid loss was observed during batch
reactor experiments [17]. Experiments showed that
overexpression of CaiD by TS results in a racemase
activity capable of transforming D(+)-carnitine into L())-
carnitine, although with c-butyrobetaine production.
High-cell-density reactors
In recombinant-protein production, not only is a high
level of gene expression important but also a high-cell-
density reactor, meaning that cell-recycling membrane
reactors oﬀer good possibilities for improving produc-
tivity and ﬁnal product concentrations as well as the ge-
netic stability of strains [36]. Moreover, for transformed
strains in continuous reactors, conditions must be
established in which plasmid copy number, transcription,
and translation eﬃciency are optimally balanced to
maximize productivity. Furthermore, strategies need to
be found to understand cell physiology in process con-
ditions, using the transformed cells in the chosen reactor
and subjecting them to production conditions in order to
ascertain their dynamic responses. Results showed that
TS is segregationally and structurally unstable in con-
tinuous high-cell-density membrane reactors under the
conditions tested. Nevertheless, since medium composi-
tion strongly aﬀects structural instability, new studies in
which the the growth rate is decreased by controlling the
medium composition are currently underway.
WS cells were also cultured anaerobically at 37 C in a
continuous reactor in which they were retained by means
of diﬀerent microﬁltration membranes (assembled in ﬂat-
sheet modules) of 0.1-lm pore size and subjected to
recycling. It was concluded that the continuous produc-
tion of L())-carnitine from crotonobetaine byWS in a cell-
recycle reactor could reach values as high as 6.5 g/l/h [1,
9], with L())-carnitine conversions of 35–46%. In order to
assess the stability and potential productivity of the
reactor, we carried out perturbation studies, changing the
dilution rate and crotonobetaine concentration, and fol-
lowed the eﬀects on strains of E. coliWS and Proteus sp.
(kindly provided by Sigma-Tau, Roma, Italy) [8, 34].
Biotransformation resulted in nearly the same L())-carni-
tine yield as obtained in the previous operation, though
with nearly double the productivity (11.5 g L())-carnitine/
l/h). Thus, WS was shown to be suitable for process
operation and even capable of being subjected to dynamic
stress, which may be useful for control and optimization
strategies [1]. Moreover, L())-carnitine dehydratase
activity/biomass ratio decreased. This fact is important
andmight imply cellular control of the biotransformation
catalysis reaction, which, to our knowledge, has not pre-
viously been detected in trimethylammoniummetabolism
studies in E. coli. Furthermore, the reactor was remark-
ably robust throughout the experimental run. Currently,
our work is directed at ﬁnding the link between central
carbon or primary metabolism and secondary carnitine
metabolism of E. coli, in order to be able to redirect the
metabolic ﬂuxes. Cell metabolic engineering tools will
then be applied for process optimization.
Conclusions
Maintaining culture collections requires commitment,
hard work and continuous research (not always with
Fig. 3 Escherichia coli O44 K74 growth and biotransformation of
trimethylammonium compounds on synterized glass for cell
immobilization at A ·35 (bar 1 mm), B ·3,700 (bar 10 lm), and
C ·23,000 (bar 1 lm). Experiments were carried out at 37 C using
a complex medium supplemented with 50 mM fumarate under
anaerobiosis
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the best means), although the eﬀort involved is not
always acknowledged by the scientiﬁc community.
Culture collections have helped not only in the devel-
opment of food-production-related processes, but also
in the simple non-sterile production of solvents, organic
acids, biomass, etc., and the complex sterile production
of pharmaceutical and ﬁne chemicals. The important
contribution of culture collections to biochemistry in
the areas of enzymology, molecular biology, genetic
engineering, and bioprocess engineering in the form of
help and advice, as well as the transmission of know-
how, should be recognized and acknowledged. This
review has provided some examples to show the strong
links between culture collections and biochemistry and
biotechnology in order to highlight their importance in
our changing and evolving world.
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